Skip to main content
Insights
/ Webinars

Centralizing Alliance Management, with Novo Nordisk

Novo Nordisk
Thu, Oct 15, 2026
16:00 CET | 10:00 EST
Centralizing Alliance Management, with Novo Nordisk

Reserve your seat

First name
Last name
Business email
Company name
Job title
Which sector best reflects your role?
By submitting this form, you agree to receive email communications from Inpart as well as the storing and processing of your personal data by Inpart as detailed in the Privacy Statement. You may unsubscribe from these communications at any time.

Alliance Management is where a partnership's scientific and commercial potential is realized. Join Inpart and Novo Nordisk for a live conversation on the operational best practices, and the platform, that keep alliances on track.

Panelists

Shuvadeep Mitra
Shuvadeep Mitra
Director - Corporate Alliance Management & Integration — Novo Nordisk
Daniel Goday Sagarra
Daniel Goday Sagarra
Project Manager - External Innovation Executive Office — Novo Nordisk
Julie Settipani
Julie Settipani
Product Director — Inpart

What you'll learn

  • How Novo Nordisk structures Alliance Management operationally, with case studies from their own partnerships
  • How Novo Nordisk uses Inpart Deal as a single source of truth across Alliance Management and BD operations, including reporting and system integrations
  • A demo from Inpart on how digital capabilities are streamlining Alliance Management
  • Live audience Q&A

Who should attend

  • Alliance Management and BD&L leaders
  • M&A, transactions, and due diligence teams
  • Search & Evaluation professionals
  • BD leads and lead scientists at biotech companies
  • Technology transfer professionals and lead scientists at research institutes

About Novo Nordisk

Novo Nordisk is a global healthcare company with more than a century of experience driving change to defeat serious chronic diseases.

About the Speakers

Shuvadeep leads strategic alliances & partnerships across clinical and commercial assets, diagnostics, and technology. He manages alliances spanning the United States, Europe, and China, driving collaboration models that accelerate innovation and deliver mutual value. His responsibilities encompass the end-to-end alliance lifecycle — from governance design and integration planning to optimizing long-term value creation and partner engagement. Daniel holds +5 years of biopharma experience: focused in External Innovation and BD strategy & porfolio management. He is dedicated to enhance end-to-end Novo Nordisk's partnering capabilities within R&D: from outreach, scouting and due diligence to partnership project and alliance portfolio management.

About Inpart

Inpart is the partnering intelligence platform 70% of the world's top 50 pharma companies use to manage biopharma partnering, from search and evaluation through Alliance Management.